Status:
COMPLETED
Non-pharmacological Intervention for Preclinical Alzheimer's Disease
Lead Sponsor:
XuanwuH 2
Conditions:
Alzheimer Disease
Functional Food
Eligibility:
All Genders
50-79 years
Phase:
NA
Brief Summary
Alzheimer's disease (AD) is the most common form of neurodegenerative disorders leading to dementia. Currently, there has been no effective drugs targeting this disease. Functional food is considered ...
Detailed Description
Currently, there has been no effective therapy for Alzheimer's disease (AD). Functional food is now considered as a potentially non-pharmacologic intervention and supplementation of functional food ma...
Eligibility Criteria
Inclusion
- 50-79 years old, right-handed and Mandarin-speaking subjects;
- self-experienced persistent decline in cognitive capacity in comparison with a previously normal status and unrelated to an acute event;
- normal age-adjusted, gender-adjusted and education-adjusted performance on standardised cognitive tests;
- concerns (worries) associated with memory complaint;
- failure to meet the criteria for MCI or dementia
Exclusion
- a history of stroke;
- major depression (Hamilton Depression Rating Scale score \> 24 points);
- other central nervous system diseases that may cause cognitive impairment, such as Parkinson's disease, tumors, encephalitis and epilepsy;
- cognitive impairment caused by traumatic brain injury;
- systemic diseases, such as thyroid dysfunction, syphilis and HIV;
- a history of psychosis or congenital mental growth retardation.
Key Trial Info
Start Date :
April 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04279418
Start Date
April 1 2019
End Date
December 31 2019
Last Update
February 21 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Neurolgy, Xuanwu Hospital of Capital Medical University
Beijing, Beijing Municipality, China, 100053